Anti-NaPi2b / SLC34A2 Reference Antibody (Lifastuzumab vedotin), IgG1
Artikelnummer:
SYB-CHB263
| Artikelname: |
Anti-NaPi2b / SLC34A2 Reference Antibody (Lifastuzumab vedotin), IgG1 |
| Artikelnummer: |
SYB-CHB263 |
| Hersteller Artikelnummer: |
CHB263 |
| Alternativnummer: |
SYB-CHB263-100UG,SYB-CHB263-1MG |
| Hersteller: |
Sanyou Bio |
| Kategorie: |
Antikörper |
| Applikation: |
ELISA, FA, FACS, Kinetics |
| Spezies Reaktivität: |
Human |
| Alternative Synonym: |
RG7599, DNIB0600A |
| Lifastuzumab vedotin is an ADC consisting of an anti-NaPi2b monoclonal antibody conjugated to the cytotoxic agent MMAE |
| Konzentration: |
1mg/ml |
| Molekulargewicht: |
145 kDa |
| Isotyp: |
IgG1 |
| NCBI: |
95436 |
| Puffer: |
25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2) |
| Reinheit: |
>90% |
| Formulierung: |
Lyophilized |
| Target-Kategorie: |
NaPi2b / SLC34A2 |
